Ronan Levy - Field Trip Founder CEO

FTHWFDelisted Stock  USD 0.04  0.00  0.00%   

Insider

Ronan Levy is Founder CEO of Field Trip Health
Age 43
Phone833-222-0084
Webhttps://www.fieldtriphealth.com

Similar Executives

Showing other executives

INSIDER Age

Lena MoranAdamsTelix Pharmaceuticals Limited
N/A
Jyoti BappScTelix Pharmaceuticals Limited
N/A
Christine MBASAB Biotherapeutics
69
Christian DavisTelix Pharmaceuticals Limited
N/A
MD MBAMAIA Biotechnology
55
Theis MDGH Research PLC
48
Andreas MDTelix Pharmaceuticals Limited
N/A
Daniel WadsworthArch Therapeutics
69
John LynchIndia Globalization Capital
N/A
Parag MallickNautilus Biotechnology
48
BSc BScTelix Pharmaceuticals Limited
N/A
Kyung NamWortmanCellectis SA
53
Terrence MDArch Therapeutics
58
M MukundaIndia Globalization Capital
N/A
Michael AbramsArch Therapeutics
53
Joseph McGuireMAIA Biotechnology
66
Ana StegicAntibe Therapeutics
N/A
Dr MBACellectis SA
46
MSc MScCellectis SA
54
Anna MowryNautilus Biotechnology
41
Kyahn WilliamsonTelix Pharmaceuticals Limited
N/A
Field Trip Health Wellness Ltd. operates health centers that provides psychedelic therapies in North America and Europe. Field Trip operates under Biotechnology classification in the United States and is traded on OTC Exchange. Field Trip Health [FTHWF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Field Trip Health Leadership Team

Elected by the shareholders, the Field Trip's board of directors comprises two types of representatives: Field Trip inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Field. The board's role is to monitor Field Trip's management team and ensure that shareholders' interests are well served. Field Trip's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Field Trip's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ronan Levy, Founder CEO
Chet Lakhani, VP Product
Donna Wong, VP Inc
Vicki Reed, Chief Officer
Mujeeb Jafferi, Founder Pres
Amardeep Manhas, Chief Officer
Stacey Hoisak, Sr Counsel
Edgar Diaz, VP Operations

Field Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Field Trip a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Consideration for investing in Field Pink Sheet

If you are still planning to invest in Field Trip Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Field Trip's history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Valuation
Check real value of public entities based on technical and fundamental data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities